Extension of Time to File SOU

WELLVII

ARC Devices Ltd.

Request for Extension of Time to File a Statement of Use

PTO- 1581
Approved for use through 12/31/2020. OMB 0651-0054
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

Request for Extension of Time to File a Statement of Use
(15 U.S.C. Section 1051(d))


The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 88858210
LAW OFFICE ASSIGNED LAW OFFICE 121
MARK SECTION
MARK WELLVII (see, http://uspto.report/TM/88858210/mark.png)
STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
LITERAL ELEMENT WELLVII
OWNER SECTION (current)
NAME ARC Devices Ltd.
INTERNAL ADDRESS c/o DLI Law
MAILING ADDRESS 12 Merrion Square
CITY Dublin 2
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY Ireland
PHONE 512-539-8753
EMAIL XXXX
OWNER SECTION (proposed)
NAME ARC Devices Ltd.
INTERNAL ADDRESS c/o DLI Law
MAILING ADDRESS 12 Merrion Square
CITY Dublin 2
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY Ireland
PHONE 512-539-8753
EMAIL XXXX
CORRESPONDENCE INFORMATION (current)
NAME Laura A. Genovese
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE lgenovese@kassgen.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) csmith@kassgen.com
CORRESPONDENCE INFORMATION (proposed)
NAME Laura A. Genovese
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE lgenovese@kassgen.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) csmith@kassgen.com
DOCKET/REFERENCE NUMBER VITAL.1001
GOODS AND/OR SERVICES SECTION
INTERNATIONAL CLASS 010
CURRENT IDENTIFICATION Apparatus for blood analysis; Blood glucose meter; Blood oxygen monitors; Blood pressure measuring apparatus; Blood pressure monitors; Blood pressure transducers; Blood pressure and diabetic diagnostic medical devices; Blood pretreatment apparatus and instruments; Devices for measuring blood sugar; Devices for measuring blood sugar for medical purposes; Devices for monitoring blood glucose for medical purposes; Electronic temperature monitors for medical use; Medical apparatus and instruments for monitoring blood oxygen saturation, blood gas concentrations, and vital signs; Medical apparatus and instruments for monitoring blood oxygen saturation, blood gas concentrations, vital signs and respiratory events; Medical apparatus and instruments for monitoring blood oxygen saturation, blood gas concentrations, vital signs and respiratory events, and downloadable software for recording, processing and transmitting medical data, for use therewith, sold as a unit; Medical apparatus and instruments for monitoring blood oxygen saturation, blood gas concentrations, vital signs and respiratory events, and recorded software for recording, processing and transmitting medical data, for use therewith, sold as a unit; Medical apparatus and instruments for monitoring blood properties and respiratory events; Medical apparatus and instruments for monitoring vital signs, blood properties and respiratory events; Medical apparatus and instruments for monitoring vital signs, blood properties and respiratory event; Medical apparatus and instruments for use in positron emission tomography (PET) imaging used to monitor brain, heart and metabolic functions; Medical devices for monitoring blood oxygen saturation, blood gas concentrations, respiratory events, and vital signs, and also featuring a system consisting of electronics for transmitting monitored data through the Internet, as a component of the medical devices; Medical instruments for measuring and displaying vital signs, blood properties and respiratory events; Medical apparatus for monitoring vital signs of patients; Medical devices, namely, patient monitors and patient sensors for monitoring and measuring blood properties and respiratory events; Patient medical monitors for monitoring systolic blood pressure, diastolic blood pressure, blood glucose levels, blood perfusion, pulse rate, heart rate, blood oxygenation saturation (SPO2), heart rate variability, respiration rate, core body temperature, weight and electrocardiogram (ECG); Portable medical devices with sensors to monitor the physical movements of a patient wearing or carrying the device; Arterial blood pressure measuring apparatus; Health monitoring devices consisting of blood pressure monitors, thermometers and pedometers; Medical devices for monitoring blood oxygen saturation, blood gas concentrations and vital signs; Medical devices for monitoring blood oxygen saturation, blood gas concentrations, vital signs and respiratory events; Medical devices for monitoring blood oxygen saturation, blood gas concentrations, vital signs and respiratory events, and downloadable software for recording, processing and transmitting medical data, for use therewith, sold as a unit; Medical devices for monitoring blood oxygen saturation, blood gas concentrations, vital signs and respiratory events, and recorded software for recording, processing and transmitting medical data, for use therewith, sold as a unit; Medical devices for monitoring blood properties and respiratory events; Medical diagnostic apparatus, analytical apparatus for medical purposes and blood pressure measuring apparatus; Medical instruments to measure blood pressure, cardiac output and other physiological and cardiovascular parameters
GOODS OR SERVICES KEEP ALL LISTED
EXTENSION SECTION
EXTENSION NUMBER 1
ALLOWANCE MAIL DATE 09/29/2020
STATEMENT OF USE NO
PAYMENT SECTION
NUMBER OF CLASSES 1
SUBTOTAL AMOUNT [EXTENSION FEE] 125
TOTAL AMOUNT 125
SIGNATURE SECTION
SIGNATURE /Robert T. Faber/
SIGNATORY'S NAME Robert T. Faber
SIGNATORY'S POSITION Chief Financial Officer
DATE SIGNED 02/12/2021
SIGNATORY'S PHONE NUMBER xxx
SIGNATURE METHOD Sent to third party for signature
FILING INFORMATION
SUBMIT DATE Fri Feb 12 11:48:22 ET 2021
TEAS STAMP USPTO/ESU-XXXX:XXXX:XXXX:
XXXX:XXXX:XXXX:XXXX:XXXX-
20210212114822304491-8885
8210-760958f26293dc04eb49
7d665f4845115111c896c5582
56e3c9a64bc13131-CC-48192
665-20210212092158744601



PTO- 1581
Approved for use through 12/31/2020. OMB 0651-0054
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number


SOU Extension Request
(15 U.S.C. Section 1051(d))


To the Commissioner for Trademarks:

MARK: WELLVII (see, http://uspto.report/TM/88858210/mark.png)
SERIAL NUMBER: 88858210

OWNER AND/OR ENTITY INFORMATION
The owner proposes to amend the following:
Current: ARC Devices Ltd., having an address of
      c/o DLI Law
      12 Merrion Square
      Dublin 2,
      Ireland
      Phone: 512-539-8753
      Email: XXXX
Proposed: ARC Devices Ltd., having an address of
      c/o DLI Law
      12 Merrion Square
      Dublin 2,
      Ireland
      Phone: 512-539-8753
      Fax:
      Email: XXXX

The owner requests a six-month extension of time to file the Statement of Use under 37 C.F.R. Section 2.89 in this application.    The Notice of Allowance mailing date was 09/29/2020.

For International Class 010:
Current identification: Apparatus for blood analysis; Blood glucose meter; Blood oxygen monitors; Blood pressure measuring apparatus; Blood pressure monitors; Blood pressure transducers; Blood pressure and diabetic diagnostic medical devices; Blood pretreatment apparatus and instruments; Devices for measuring blood sugar; Devices for measuring blood sugar for medical purposes; Devices for monitoring blood glucose for medical purposes; Electronic temperature monitors for medical use; Medical apparatus and instruments for monitoring blood oxygen saturation, blood gas concentrations, and vital signs; Medical apparatus and instruments for monitoring blood oxygen saturation, blood gas concentrations, vital signs and respiratory events; Medical apparatus and instruments for monitoring blood oxygen saturation, blood gas concentrations, vital signs and respiratory events, and downloadable software for recording, processing and transmitting medical data, for use therewith, sold as a unit; Medical apparatus and instruments for monitoring blood oxygen saturation, blood gas concentrations, vital signs and respiratory events, and recorded software for recording, processing and transmitting medical data, for use therewith, sold as a unit; Medical apparatus and instruments for monitoring blood properties and respiratory events; Medical apparatus and instruments for monitoring vital signs, blood properties and respiratory events; Medical apparatus and instruments for monitoring vital signs, blood properties and respiratory event; Medical apparatus and instruments for use in positron emission tomography (PET) imaging used to monitor brain, heart and metabolic functions; Medical devices for monitoring blood oxygen saturation, blood gas concentrations, respiratory events, and vital signs, and also featuring a system consisting of electronics for transmitting monitored data through the Internet, as a component of the medical devices; Medical instruments for measuring and displaying vital signs, blood properties and respiratory events; Medical apparatus for monitoring vital signs of patients; Medical devices, namely, patient monitors and patient sensors for monitoring and measuring blood properties and respiratory events; Patient medical monitors for monitoring systolic blood pressure, diastolic blood pressure, blood glucose levels, blood perfusion, pulse rate, heart rate, blood oxygenation saturation (SPO2), heart rate variability, respiration rate, core body temperature, weight and electrocardiogram (ECG); Portable medical devices with sensors to monitor the physical movements of a patient wearing or carrying the device; Arterial blood pressure measuring apparatus; Health monitoring devices consisting of blood pressure monitors, thermometers and pedometers; Medical devices for monitoring blood oxygen saturation, blood gas concentrations and vital signs; Medical devices for monitoring blood oxygen saturation, blood gas concentrations, vital signs and respiratory events; Medical devices for monitoring blood oxygen saturation, blood gas concentrations, vital signs and respiratory events, and downloadable software for recording, processing and transmitting medical data, for use therewith, sold as a unit; Medical devices for monitoring blood oxygen saturation, blood gas concentrations, vital signs and respiratory events, and recorded software for recording, processing and transmitting medical data, for use therewith, sold as a unit; Medical devices for monitoring blood properties and respiratory events; Medical diagnostic apparatus, analytical apparatus for medical purposes and blood pressure measuring apparatus; Medical instruments to measure blood pressure, cardiac output and other physiological and cardiovascular parameters

For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this specific class.


This is the first extension request.

Correspondence Information (current):
      Laura A. Genovese
      PRIMARY EMAIL FOR CORRESPONDENCE: lgenovese@kassgen.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): csmith@kassgen.com

Correspondence Information (proposed):
      Laura A. Genovese
      PRIMARY EMAIL FOR CORRESPONDENCE: lgenovese@kassgen.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): csmith@kassgen.com


Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the owner/holder and the owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).





A fee payment in the amount of $125 will be submitted with the form, representing payment for 1 class.


Declaration

STATEMENTS: The signatory believes that: the applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all the goods/services under Section 1(b) in the notice of allowance or as subsequently modified, or, if applicable, the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with all the goods/services/collective membership organization under Section 1(b) in the notice of allowance or as subsequently modified; and that to the best of the signatory's knowledge and belief, no other persons, except, if applicable, members and concurrent users, have the right to use the mark in commerce, either in the identical form or in such near resemblance as to be likely, when used on or in connection with the goods/services/collective membership organization of such other persons, to cause confusion or mistake, or to deceive.

DECLARATION: The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. §1001, and that such willful false statements and the like may jeopardize the validity of the application or submission or any resulting registration, declares that all statements made of his/her own knowledge are true and that all statements made on information and belief are believed to be true.


Signature: /Robert T. Faber/      Date Signed: 02/12/2021
Signatory's Name: Robert T. Faber
Signatory's Position: Chief Financial Officer
Signatory's Phone: xxx
Signature method: Sent to third party for signature

PAYMENT: 88858210
PAYMENT DATE: 02/12/2021

Serial Number: 88858210
Internet Transmission Date: Fri Feb 12 11:48:22 ET 2021
TEAS Stamp: USPTO/ESU-XXXX:XXXX:XXXX:XXXX:XXXX:XXXX:
XXXX:XXXX-20210212114822304491-88858210-
760958f26293dc04eb497d665f4845115111c896
c558256e3c9a64bc13131-CC-48192665-202102
12092158744601




uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed